To gain insight into the evolution of telaprevir-resistant variants , their baseline prevalence and persistence after treatment was investigated using a more sensitive , deep-sequencing ( DS ) technique in a large number of treatment-experienced patients from the REALIZE study who were infected with hepatitis C virus genotype 1 .